Zobrazeno 1 - 10 of 82 pro vyhledávání: '"Eberhard Varenhorst"'
1
Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer
Autor: Maria, Ebbinge, Anders, Berglund, Eberhard, Varenhorst, Per Olov, Hedlund, Gabriel, Sandblom, Reinhard, Stege
Publikováno v: Scandinavian Prostate Cancer Group (SPCG)-5 Study Group (Ole Steen Nielsen, member of-) 2018, ' Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer ', BJU International, vol. 122, no. 4, pp. 583-591 . https://doi.org/10.1111/bju.14227
OBJECTIVE: To estimate the strength of change in haemoglobin (Hb) concentrations during 1 year of androgen-deprivation therapy (ADT) as a predictor of survival in hormone-naïve patients with bone-metastatic (Stage M1b) prostate cancer.PATIENTS AND M
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::313e77ab61fa093e450e7a566756fe6b
https://doi.org/10.1111/bju.14227
Zobrazit plný text záznamu
2
The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades
Autor: Gabriel Sandblom, Rami Klaff, Eberhard Varenhorst, Johan Rosell
Publikováno v: Urology. 91:77-82
To identify prognostic factors, and to estimate the long-term disease-specific and annual disease-specific mortality rates of low-risk prostate cancer patients from the early prostate-specific antigen (PSA) era.We studied data extracted from the Sout
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf9d658485d993cd9c5bc2c4341075b
https://doi.org/10.1016/j.urology.2016.01.033
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases
Autor: Eberhard Varenhorst, Anders Berglund, Rami Klaff, Gabriel Sandblom, Per Olov Hedlund
Publikováno v: Cancer Medicine
Approximately 15% of men with hormone naive metastatic prostate cancer primarily fail to respond to androgen deprivation treatment (ADT). The reason why the response to ADT differs in this subgroup of men with prostate cancer remains unclear. The aim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35e0636965a83e7d7a6f2fa8669dd24
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-127443
Zobrazit plný text záznamu
5
Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL
Autor: Anders Widmark, Eberhard Varenhorst, Anders Berglund, Gabriel Sandblom, Sam Ladjevardi, Ola Bratt
Publikováno v: BJU International. 111:381-388
Objective less thanbrgreater than less thanbrgreater thanTo investigate the influence of curative treatment on cause-specific mortality in men diagnosed with prostate cancer (PCa) with serum prosta ...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ee0e4d7c0ae6be555b3b072db409c83
https://doi.org/10.1111/j.1464-410x.2012.11320.x
Zobrazit plný text záznamu
6
Inflammation, Focal Atrophic Lesions, and Prostatic Intraepithelial Neoplasia with Respect to Risk of Lethal Prostate Cancer
Autor: Jennifer R. Rider, Ove Andrén, Sabina Davidsson, Eberhard Varenhorst, Fang Fang, Lorelei A. Mucci, Michelangelo Fiorentino, Katja Fall
Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 20:2280-2287
Background: A challenge in prostate cancer (PCa) management is identifying potentially lethal disease at diagnosis. Inflammation, focal prostatic atrophy, and prostatic intraepithelial neoplasia (PIN) are common in prostate tumor specimens, but it is
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::963b8cabc353013c5a52b3c1b54181bb
https://doi.org/10.1158/1055-9965.epi-11-0373
Zobrazit plný text záznamu
7
PSA Kinetics Provide Improved Prediction of Survival in Metastatic Hormone-Refractory Prostate Cancer
Autor: Gabriel Sandblom, Gunnar Aus, David Robinson, Per Olov Hedlund, Robert Johansson, Hans Garmo, Eberhard Varenhorst
Publikováno v: Urology. 72:903-907
OBJECTIVES To assess the value of prostate-specific antigen (PSA) kinetics in predicting survival and relate this to the baseline variables in men with metastatic hormone-refractory prostate cancer (HRPC). METHODS The data from 417 men with HRPC were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea39cc862ba143f1f31090f4a1c2497f
https://doi.org/10.1016/j.urology.2008.05.026
Zobrazit plný text záznamu
8
Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer
Autor: Katja Fall, Francesca Demichelis, Yudi Pawitan, Swen Olof Andersson, Sven Perner, Ove Andrén, Jan-Erik Johansson, Hans-Olov Adami, Stefano Calza, Arul M. Chinnaiyan, Kirsten D. Mertz, Philip W. Kantoff, Todd R. Golub, Laura A. Johnson, Yujin Hoshida, Mathieu Lupien, Eberhard Varenhorst, Sunita R. Setlur, Mark A. Rubin, Jeff Tang, Myles Brown, Meir J. Stampfer, Lorelei A. Mucci, Scott A. Tomlins, Daniel R. Rhodes, Andrea Sboner
Publikováno v: JNCI: Journal of the National Cancer Institute. 100:815-825
The majority of prostate cancers harbor gene fusions of the 5'-untranslated region of the androgen-regulated transmembrane protease serine 2 (TMPRSS2) promoter with erythroblast transformation-specific transcription factor family members. The common
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72441a58be25e94a3854122fac3fc844
https://doi.org/10.1093/jnci/djn150
Zobrazit plný text záznamu
9
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
Autor: Per Olov, Hedlund, Jan-Erik, Damber, Inger, Hagerman, Svein, Haukaas, Peter, Henriksson, Peter, Iversen, Robert, Johansson, Peter, Klarskov, Finn, Lundbeck, Finn, Rasmussen, Eberhard, Varenhorst, Jouko, Viitanen, Hans, Wolf
Publikováno v: Hedlund, P O, Damber, J-E, Hagerman, I, Haukaas, S, Henriksson, P, Iversen, P, Johansson, R, Klarskov, P, Lundbeck, F, Rasmussen, F, Varenhorst, E, Viitanen, J & SPCG-5 Study Group 2008, ' Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5 ', Scandinavian Journal of Urology and Nephrology, vol. 42, no. 3, pp. 220-9 . https://doi.org/10.1080/00365590801943274
Udgivelsesdato: 2008-null OBJECTIVE: To compare parenteral estrogen therapy in the form of high-dose polyestradiol phosphate (PEP; Estradurin) with combined androgen deprivation (CAD) in the treatment of prostate cancer patients with skeletal metasta
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd5ec055c502b622c798fcc8e49b8f58
https://doi.org/10.1080/00365590801943274
Zobrazit plný text záznamu
10
The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate
Autor: Gabriel Sandblom, Hans Garmo, Sam Ladjevardi, Eberhard Varenhorst
Publikováno v: Cancer. 112:813-819
To evaluate the predictive value of prostate-specific antigen (PSA) in a population-based cohort, the authors analyzed relative survival in all men with localized prostate cancer who were registered in the Swedish National Prostate Cancer Register (N
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fae37b7ee994de13b2dc1c86c312341
https://doi.org/10.1002/cncr.23235
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje